Resetting the tipping point: Converting immune checkpoint non-responders into responders.

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1103980

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Although immunotherapy has recently shown a breakthrough in the treatment of lung cancers, with long-term full regression of the cancer in some patients, most patients unfortunately do not respond. In this proposal, we want to characterise the events that occur in a cancer that is cured by immunotherapy, while it regresses. By subsequently reinforcing those processes, we aim to tip the balance towards a response, thereby increasing the cure rate.

Funded Activity Details

Start Date: 01-01-2016

End Date: 01-01-2018

Funding Scheme: Project Grants

Funding Amount: $455,135.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cancer Therapy (excl. Chemotherapy and Radiation Therapy)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cancer biology | immunotherapy | lung cancer | mesothelioma | systems biology

Related Links